AtriCure, Inc. has grown revenue 16% a year over three years and 19% a year over five. Revenue growth, 3-year annual rate: +16% (Medical Instruments & Supplies median +9.8%). Revenue growth, 5-year rate: +19%, growth has slowed since the five-year average. Years of annual history on file: 17, FY2009 to FY2025, as filed.

ATRCAtriCure, Inc.

Healthcare

$55.80+53% 1Y

$55.80

$25.8652 weeks$60.73

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue growing +14% year on year and operating margin widening (+9.0 points), but earnings down −127% year on year.

2 good, 1 to watch

Revenue trend+14% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +19% a year.

Earnings trend−127% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction+9.0 points operating

Trailing-twelve-month operating margin, 2.1% now against -6.9% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbetter than 83% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is ATRC growing?

AtriCure, Inc. has grown revenue 16% a year over three years and 19% a year over five.

+16%

Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +9.8% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +19%
Revenue growth, 5-year rate · +16% over three · growth has slowed since the five-year average
Years of annual history on file: 17
Years of annual history on file · FY2009 to FY2025, as filed

Details›